Bringing the fundamentals into focus…
Back to Anbio Biotechnology
How Anbio Biotechnology stacks up
NNNN · against 557 other Healthcare companies listed in US-listed
Profitability
95/ 100
Near the top of its peers.
Ranked #27 of 558 · scores higher than 94% of peers
Bars: peers in each 10-point band of the profitability score61 peers with a profitability score of 90–100, including NNNN · Click a bar to see the companies
Why profitability scores 95?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its operating margin, return on assets and return on invested capital, which are stronger than most Healthcare peers.
- a higher return on invested capital: stronger than 86% of peers. Return on invested capital: 20.4% vs peer median 4.7%
- a higher return on assets: stronger than 98% of peers. Return on assets: 21.2% vs peer median 1.7%
- a wider operating margin: stronger than 100% of peers. Operating margin: 66.7% vs peer median 7.1%
Metric by metric
Position: dot = NNNN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | NNNN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 517 reported | 20.4% | -7.0% | 88% | 33% | |
| Operating marginHigher is better · 479 reported | 66.7% | -2.4% | 100% | 33% | |
| Return on assetsHigher is better · 582 reported | 21.2% | -7.8% | 96% | 33% | |
| Return on equityHigher is better · 531 reported | 27.0% | -19.7% | 91% | Context only | |
| Gross marginHigher is better · 601 reported | 87.2% | 43.9% | 89% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around NNNN| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 52.9B USD | 99 | 57 | |
| 1 | 578M USD | 99 | 73 | |
| 27 | 5.8B USD | 95 | 68 | |
| 27 | 14.6B USD | 95 | 59 | |
| 27 | 9.4B USD | 95 | 70 | |
| 27 | 2.2B USD | 95 | 78 | |
| 27 | 157M USD | 95 | ||
| 27 | 25.8B USD | 95 | 75 | |
| 27 | 34.3B USD | 95 | 57 | |
| 35 | 2.6B USD | 94 | 66 | |
| 35 | 155.7B USD | 94 | 64 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score